Apr 08, 2026
Stroke remains one of the most critical challenges in modern medicine, representing a leading cause of long-term disability and mortality worldwide. According to the World Health Organization (WHO), stroke is responsible for approximately 11% of total deaths globally. Within this landscape, Acute Ischemic Stroke (A...
Read More...
Mar 05, 2026
Abbott’s Next‑Generation Cardiomems™ Remote Heart Failure Monitoring Reader Received FDA Approval to Enhance Patient Experience and Help Detect Disease Progression On 27 February 2026, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved the company’s CardioMEMS™ HERO device, a ne...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper